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OBJECTIVES The purpose of this study was to assess the relationship between body mass index (BMI) and
the prognostic value of myocardial perfusion single-photon emission computed tomography
(MPS).
BACKGROUND The prognostic value of MPS in the obese has not been evaluated.
METHODS We studied 4,720 patients with and 10,019 patients without known coronary artery disease
(CAD) who underwent rest Tl-201/stress Tc-99m sestamibi MPS, including 5,233 gated
MPS studies and followed up (mean 2.7 to 3.2 years). Patients were categorized as normal
weight (BMI 18.5 to 24.9 kg/m2), overweight (BMI 25.0 to 29.9 kg/m2), or obese (BMI
30.0 kg/m2).
RESULTS Unadjusted annual rates of cardiac death (CD) rose versus stress MPS abnormalities in all
weight groups (p  0.001). Obese or overweight patients with or without known CAD who
had normal MPS were at low CD risk (1%/year), similar to normal weight patients. In
CAD, obese and overweight patients with abnormal MPS had lower rates of CD compared
with normal weight patients (p  0.01). In patients with low ejection fraction (EF) by gated
MPS, those with normal weight had highest CD rate (p  0.001). Multivariable models
revealed that BMI was not a predictor of CD in suspected CAD patients (hazard ratio [HR]
0.99; 95% confidence interval [CI] 0.95 to 1.02) but was an independent inverse predictor of
CD in known CAD patients (HR 0.95; 95% CI 0.92 to 0.98), especially in women, adenosine
stress, low EF, or abnormal perfusion.
CONCLUSIONS Normal MPS was associated with low risk of CD in patients of all weight categories. In
patients with known CAD undergoing MPS, obese and overweight patients were at lower
risk of CD over three years than normal weight patients. (J Am Coll Cardiol 2006;47:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.11.0621418–26) © 2006 by the American College of Cardiology Foundation
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iore than 65 million Americans are currently obese (1).
besity is associated with an increased risk for cardiovas-
ular disease and cardiac mortality in the general population
2–5). In several studies, however, higher body mass index
BMI) has been reported to correlate with greater survival
mong patients with chronic heart failure (CHF) (6,7),
yocardial infarction (MI) (8), or coronary revasculariza-
ion (9,10). Myocardial perfusion single-photon emission
omputed tomography (MPS) has been demonstrated to be
ffective for risk stratification in several subsets including
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rleans, Louisiana, November 7–10, 2004. Todd Miller, MD, FACC, acted as guest
ditor.u
Manuscript received May 16, 2005; revised manuscript received November 3, 2005,
ccepted November 11, 2005.omen, elderly, diabetics, and so on (11–14). While a large
roportion of patients undergoing stress MPS are overweight
r obese, the relationship between patient weight and prog-
ostic value of MPS has not yet been defined. Thus, the aim
f this study was to assess the prognostic value of MPS in
ormal weight, overweight, and obese patients.
ETHODS
atient population. We evaluated 16,816 consecutive
nique patients free of known non-ischemic cardiomyopa-
hy or valvular heart disease who underwent rest thallium
Tl)-201/stress Tc-99m sestamibi dual-isotope MPS with
xercise or adenosine stress between February 1991 and
ebruary 1999. All patients were prospectively enrolled in a
egistry, and follow-up data were obtained for at least one
ear after testing, after patients had given written informed
onsent for the procedure and follow-up portion of this
tudy. Informed consent (including consent to participate in
egistry) was obtained at the time of stress testing. Of the
nitial population, 765 (4.5%) patients were lost to follow-
p; 1,312 (7.6%) patients underwent early revascularization
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April 4, 2006:1418–26 Prognostic Impact of BMI on SPECTcoronary artery bypass graft surgery [CABG] or percuta-
eous coronary intervention [PCI] 60 days after index
PS) and were excluded from this analysis, as previously
escribed (15). Thus, the final population consisted of
4,739 patients (age 65  13 years, 40% women) including
,662 exercise and 5,077 adenosine stress. Of this total,
,233 patients underwent gated MPS, 10,019 with sus-
ected coronary artery disease (CAD) and 4,720 with
nown CAD (defined as history of MI or coronary
evascularization).
MI group classification. Patients were categorized by
MI [(weight in kg)/(height in meter)2] as normal weight
BMI 18.5 to 24.9 kg/m2, n  5,715), overweight (BMI
5.0 to 29.9 kg/m2, n  6,102), or obese (BMI 30.0
g/m2, n  2,922) (3,16). Weight and height were mea-
ured for all hospitalized patients and was self-reported by
ll others. Patients with low BMI (18.5 kg/m2, n  291)
ere excluded due to the small size of the group and the
igh likelihood of serious comorbidities that could distort
he prognostic relationships between BMI and MPS results.
egarding the 765 patients lost to follow-up, BMI distri-
utions were 40%, 39%, and 21% from normal weight to
bese categories, not significantly different from the study
opulation.
maging and stress protocol. Patients were injected intra-
enously at rest with Tl-201 (3 to 4.5 mCi), and MPS was
nitiated 10 min after injection (17). Exercise or adenosine
ith or without low-level treadmill exercise protocols were
hen performed as previously described (12,17), with stress
njection of Tc-99m sestamibi (25 to 40 mCi). Twelve-lead
lectrocardiography (ECG) was monitored during stress
ests.
Patients with resting defects usually underwent 24-h
edistribution Tl-201 MPS to assess reversibility. In pa-
ients studied after 1994, the post-stress acquisition em-
loyed gated MPS, and left ventricular (LV) ejection
raction (LVEF), end-systolic volume (ESV), and end-
iastolic volume (EDV) were assessed using an automatic
rogram (18).
mage interpretation and scintigraphic indexes. The
Abbreviations and Acronyms
BMI  body mass index
CABG  coronary artery bypass grafting
CAD  coronary artery disease
CHF  chronic heart failure
EDV  end-diastolic volume
EF  ejection fraction
ESV  end-systolic volume
LV  left ventricle/ventricular
LVEF  left ventricular ejection fraction
MPS  myocardial perfusion single-photon emission
computed tomography
PCI  percutaneous coronary intervention
SPECT  single-photon emission computed tomographyummed stress scores (SSS) and summed rest scores (SRS) cere obtained by adding the scores of 20 myocardial
egments (19,20). Our database system required entry of a
core for all 20 segments in each patient with no missing
alues. The sum of the differences between the SSS and
RS was defined as the summed difference score. These
ndexes were converted to percent of the total myocardium
nvolved with stress, ischemic, or fixed defects by dividing
he summed scores by 80, the maximum potential score
4  20), and multiplying by 100 (21). Stress defect 5%,
% to 10%, and10% myocardium were defined as normal,
ildly, and moderately to severely abnormal scans (22).
ecause the presence and magnitude of hypoperfusion
nduced during adenosine MPS is roughly equivalent to the
agnitude of ischemia induced during maximal exercise
23,24), we employ the term “inducible ischemia” to repre-
ent both the ischemia during exercise and adenosine MPS,
ven though actual ischemia is often not produced by the
denosine.
ollow-up data. All patients prospectively enrolled in the
ingle-photon emission computed tomography (SPECT)
egistry are routinely followed through annual contact that
as performed by experienced personnel for the determina-
ion of death status. This patient contact was made by
ailed questionnaire followed by the use of a scripted
linded telephone interview in patients not initially re-
ponding to the mailing. Deaths were identified and con-
rmed through our hospital-based patient information sys-
em (WebVS) and the Social Security death index. To
scertain the cause of death, the information provided by
ebVS and the death certificates were obtained for all who
ied in Los Angeles County and were reviewed consensually
y two blinded experienced cardiologists. Cardiac death was
efined as death from any cardiac cause (lethal arrhythmia,
yocardial infarction, pump failure, etc.). Patients not
onfirmed to be deceased and without follow-up informa-
ion (mail, telephone interview, or in WebVS) were con-
idered lost to follow-up. The average length of follow-up
as 3.2  2.0 years and represented a positively skewed
istribution of follow-up with the vast majority of values
eing within 1.0 to 4.5 years of follow-up.
tatistical analysis. All continuous variables are expressed
s means  SD. We performed univariate analyses of
ontinuous variables using an unpaired t test. Univariable
nalyses of categorical variables were compared using the
hi-square test. One-way analysis of variance with a post-
oc Bonferroni test was used to compare means of contin-
ous variables among multiple groups. Pre-test likelihood of
AD was calculated by using CADENZA based on Bayes-
an analysis of pre-scan patient data (25). A probability
alue 0.05 was considered statistically significant. Cox
roportional hazards analysis (version 10.0, SPSS Inc.,
hicago, Illinois) was applied to identify univariable and
ultivariable estimators of cardiac death. Selection of vari-
bles for our multivariable models were based on univariable
tatistical significance of p  0.05 as well as based upon
linical judgment. Age was included in our multivariable
m
w
c
w
R
C
p
n
(
p
2
p
s
g
c
t
p
(
b
b
b
C
m
f
w
t
h
M
p
0.02
am.
1420 Kang et al. JACC Vol. 47, No. 7, 2006
Prognostic Impact of BMI on SPECT April 4, 2006:1418–26odels using decile categories. Based upon these models,
e derived risk-adjusted probabilities of cardiac death and
umulative survival curves to compare normal weight, over-
eight, and obese patients.
ESULTS
linical characteristics. Compared to patients with sus-
ected CAD, those with known CAD were more often of
ormal weight (40% vs. 38%, p  0.021) and overweight
43% vs. 41%, p 0.023) but less often obese (18% vs. 21%,
 0.001) and very obese (BMI 40 kg/m2 [1.2% vs.
.1%, p  0.001]) (Tables 1 and 2).
In the known CAD group (Table 1), obese or overweight
atients were much younger, more frequently female, had
horter exercise duration, higher resting heart rate, and a
reater frequency of hypertension, diabetes mellitus, hyper-
Table 1. Characteristics of Patients With Kno
Normal Weigh
n  1,865 (40%
Age (yrs) 71  11*†
70 yrs old 1,115 (60%)*†
Gender (female) 556 (30%)*†
Hypertension 853 (46%)*†
Diabetes 294 (16%)*†
Hypercholesterolemia 940 (50%)*†
Smoking 216 (12%)
Digoxin use 266 (14%)*†
Atrial fibrillation 88 (5%)*†
Angina 865 (46%)*
Shortness of breath 165 (9%)
Resting heart rate 69  13*
Abnormal resting ECG 1,559 (84%)
Exercise test 1,100 (59%)
Exercise duration (min) 7.2  2.7*
Ischemic exercise ECG 221 (20%)
Values are n (%) or mean  SD. *p  0.02 vs. obese; †p 
CAD  coronary artery disease; ECG  electrocardiogr
Table 2. Characteristics of Patients With Susp
Normal Weig
n  3,850 (38
Age (yrs) 66  13*†
70 yrs old 1,669 (43%)*†
Gender (female) 2,022 (53%)†
Hypertension 1,492 (39%)*†
Diabetes 351 (9%)*†
Hypercholesterolemia 1,491 (39%)*†
Smoking 552 (14%)
Digoxin use 232 (6%)
Atrial fibrillation 94 (2%)
Angina 1,472 (38%)*†
Shortness of breath 203 (5%)*
Resting heart rate 69  13*†
Abnormal resting ECG 2,226 (58%)
Exercise test 2,691 (70%)*
Exercise duration (min) 7.3  2.9*
Ischemic exercise ECG 605 (22%)*
Pre-test likelihood of CAD 0.34  0.27*Values are n (%) or mean  SD. *p  0.02 vs. obese; †p  0.02
CAD  coronary artery disease; ECG  electrocardiogram.holesterolemia, and typical angina symptoms as compared
o patients at a normal weight (p  0.02). Normal weight
atients more often used digoxin and had atrial fibrillation
p  0.02). Of note, no significant difference was revealed
y type of stress performed exercise or pharmacologic stress
etween weight groups (p  NS).
In the suspected CAD group (Table 2), the differences
etween the weight groups were similar to those in the
AD group, with the following exceptions: obese patients
ore often presented with shortness of breath and less
requently had exercise stress and ischemic exercise ECG
hen compared to other weight groups (p  0.001). Addi-
ionally, normal weight patients had a lower pre-test likeli-
ood of coronary disease (p  0.001).
PS results. Myocardial perfusion SPECT findings in
atients with known and suspected CAD are shown in
AD
Overweight
n  2,029 (43%)
Obese
n  826 (18%)
68  11* 64  11
961 (47%)* 273 (33%)
463 (23%)* 297 (36%)
1,088 (54%)* 529 (64%)
388 (19%)* 272 (33%)
1,097 (54%) 474 (57%)
271 (13%) 119 (14%)
160 (8%) 68 (8%)
63 (3%) 19 (2%)
999 (49%)* 450 (54%)
141 (7%) 65 (8%)
69  13* 71  13
1,677 (83%) 689 (83%)
1,208 (60%) 465 (56%)
7.0  2.5* 6.4  2.2
259 (21%) 86 (18%)
vs. overweight.
CAD
Overweight
n  4,073 (41%)
Obese
n  2,096 (21%)
63  13* 61  12
1,433 (35%)* 556 (27%)
1,535 (38%)* 1,090 (52%)
1,968 (48%)* 1,281 (61%)
489 (12%)* 454 (22%)
1,796 (44%) 981 (47%)
553 (14%) 277 (13%)
185 (5%) 104 (5%)
119 (3%) 60 (3%)
1,673 (41%)* 971 (46%)
228 (6%) 153 (7%)
70  13* 73  14
2,296 (56%) 1,245 (59%)
2,890 (71%)* 1,308 (62%)
7.4  2.7* 6.4  2.3
598 (21%)* 182 (14%)
0.36  0.28 0.37  0.28wn C
t
)ected
ht
%)
†vs. overweight.
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April 4, 2006:1418–26 Prognostic Impact of BMI on SPECTable 3. The patients with known disease more frequently
ad abnormal MPS and had a greater frequency of fixed and
schemic perfusion defects than the patients with suspected
AD. Among the weight groups, however, there were no
ifferences in the frequency of an abnormal MPS scan and
isual LV enlargement across weight groups (p 0.20). For
hose with suspected CAD, perfusion defects were also
imilar across the weight groups, although patients with
ormal weight and the obese had slightly smaller perfusion
efects as compared to overweight patients. In patients with
ated MPS, LVEF and LV volumes were also similar
mong weight groups in known CAD patients. In patients
ith suspected CAD, normal weight patients had higher
ean ejection fraction (EF), lower EDV and ESV com-
ared to overweight or obese patients (p  0.01).
Table 3. Scintigraphic Characteristics and Car
Normal W
Patients with known CAD n  1,8
Cardiac deaths 154 (8.3
Abnormal perfusion 1,260 (68
Stress defects (% myo) 13.3  13
Fixed defects (% myo) 6.7  10
Ischemic defects (% myo) 6.4  7.
LV enlargement 433 (23
LVEF 45% 195/592 (3
LVEF (n  1,530) 0.50  0.
EDV (n  1,423) 112  69
ESV (n  1,423) 65  62
Patients with suspected CAD n  3,85
Cardiac deaths 70 (1.8
Abnormal perfusion 713 (19
Stress defects (% myo) 2.7  6.
Fixed defects (% myo) 0.5  2.
Ischemic defects (% myo) 2.2  5.
LV enlargement 221 (6%
LVEF 45% 76/1,366
LVEF (n  3,703) 0.64  0.
EDV (n  3,499) 75  36
ESV (n  3,499) 30  26
Values are n (%) or mean  SD. *p  0.02 vs. overweight;
CAD  coronary artery disease; EDV  end-diastolic vo
left ventricular ejection fraction; % myo  % of myocardium
igure 1. Annual rates of cardiac death in patients with known coronary a
black bars) as a function of myocardial perfusion single-photon emission comput
eight categories. Abnl  abnormal; Mod  moderate; Sev  severe.utcome events. The follow-up duration was 3.2  2.0
ears for patients with known CAD, 2.7  1.6 years for
atients with suspected CAD, and 2.9  1.2 years for
atients with gated MPS. The numbers of cardiac deaths in
hese two populations are shown in Table 3. During
ollow-up, the cardiac death rate was significantly higher in
he CAD group as compared to that in the suspected CAD
roup (6.3% vs. 1.8%, p  0.001). In patients with and
ithout known CAD, unadjusted annual rates of cardiac death
ncreased in each weight category as the scan abnormality
ncreased (p  0.001) (Figs. 1 and 2). In the patients with
ormal MPS, the cardiac death rate was low (1%) in all
eight groups in patients with and without known CAD
Figs. 1 and 2). Of interest, among patients with known CAD
ho had mildly or moderately to severely abnormal MPS,
eaths
Overweight Obese
n  2,029 n  826
107 (5.3%) 35 (4.2%)
1,387 (68%) 554 (67%)
13.3  12.9 12.9  12.9
5.8  9.8 5.9  9.7
7.2  8.5 6.8  8.0
457 (23%) 193 (23%)
196/640 (31%) 100/298 (34%)
0.51  0.15 0.51  0.16
114  61 122  69
63  53 67  58
n  4,073 n  2,096
71 (1.7%) 35 (1.7%)
862 (21%) 425 (20%)
3.2  7.0 2.9  6.4
0.7  3.1 0.6  2.5
2.5  5.7 2.3  5.2
288 (7%) 148 (7%)
96/1,462 (7%) 72/875 (8%)
0.61  0.12 0.61  0.12
85  38 90  41*
36  28 38  32
0.01 vs. other groups.
ESV  end-systolic volume; LV  left ventricle; LVEF 
disease by normal weight (open bars), overweight (gray bars), and obesediac D
eight
65
%)†
%)
.2
.7*
9*
%)
3%)
17
0
%)
%)
2*
8*
2*
)
(6%)
12†
†
†
†p rtery
ed tomography results. p 0.001 across scan categories; †p 0.01 across
t
(
a
c
w
w
N
h
I
w
o
M
c
k
s
c
(
t
i
F
v
d
b
b
w
a
i
t
s
t
c
fi
s
d
(
s
a
m
d
r
F
(
a
F
b
f
1422 Kang et al. JACC Vol. 47, No. 7, 2006
Prognostic Impact of BMI on SPECT April 4, 2006:1418–26hose with normal weight had the highest rates of cardiac death
both p  0.01). In patients with suspected CAD and
bnormal scans, the rates of CD were similar across weight
ategories (p  NS).
In the subgroup of patients with gated MPS (Fig. 3),
hen the post-stress EF was 45%, cardiac death rates
ere low (1%/year) regardless of weight category (p 
S). When EF was45%, patients in each weight category
ad higher event rates than the patients with EF 45%.
mportantly, among these patients with reduced EF, those
ith normal weight had twice the cardiac death rate as that
f the heavier patients (p  0.001).
ultivariable survival analysis. Significant predictors of
ardiac death as based on Cox models in patients with
nown and suspected CAD are shown in Tables 4 and 5.
In patients with known CAD, adenosine stress was the
trongest independent predictor followed by percent myo-
ardium with stress defect and other significant predictors
Table 4). Both BMI and gender were independent predic-
ors of cardiac death in this group; lower risk was noted with
ncreasing BMI (p  0.001) and in men (p  0.033).
urther, a significant interaction was present between these
igure 2. Annual rates of cardiac death in patients with suspected coronary
black bars) as a function of myocardial perfusion single-photon emissio
bnormal; Mod  moderate; Sev  severe.
igure 3. Annual rates of cardiac death in patients with gated myocardial p
ars), overweight (gray bars), and obese (black bars) in normal and abnormal eje
raction.ariables, such that BMI did not impact risk in men, but risk
ecreased with increasing BMI in women. The interaction
etween weight category and stress defect was also tested
ut was not significant.
In further assessment of the known CAD patients, there
ere 104 (2.2%) cardiac deaths occurring in the first year
fter MPS, including 57 (3.1%), 36 (1.8%), and 11 (1.3%)
n the normal weight, overweight, and obese groups, respec-
ively. During this first year, the cardiac death rate was
ignificantly higher in the normal weight patients compared
o patients in the other categories (p  0.015 for both
omparisons). Importantly, even when patients with these
rst-year cardiac deaths were excluded, BMI remained a
ignificant reverse predictor of the 192 remaining cardiac
eaths after adjusting for the other independent predictors
p  0.011).
In patients with suspected CAD, percent myocardium at
tress was the single greatest predictor, followed by age and
denosine stress, and other variables listed in Table 5. Body
ass index was not an independent predictor for cardiac
eath (p  0.26). There were no significant interactions
evealed in this group.
y disease by normal weight (open bars), overweight (gray bars), and obese
puted tomography results. p  0.001 across scan categories. Abnl 
on single-photon emission computed tomography by normal weight (openarter
n comerfusi
ction fraction groups. p  0.001 across weight categories. EF  ejection
s
s
C
w
R
s
r
m
w
p
v
a
c
(
t
i
v
e
i
o
f
a
0
E
p
c
p
s
a
w
h
p
O
c
s
o
w
c
s
w
T
i
A
%
E
A
R
H
A
B
S
D
D
M
B
*
a
T
i
%
A
A
A
E
S
D
D
R
B
*
T
i
S
N
M
M
M


W


E
A
L
L
C
m
p
T
i
A
N
M
M
M


W


E
A
L
L
1423JACC Vol. 47, No. 7, 2006 Kang et al.
April 4, 2006:1418–26 Prognostic Impact of BMI on SPECTFor the models in Tables 4 and 5, gender, hypertension,
moking, family history of CAD, atrial fibrillation, angina
ymptom, ischemic stress ECG, and pre-test likelihood of
AD, as well as possible interactions, were analyzed and
ere not found to be significant predictors.
isk-adjusted probabilities of cardiac death in BMI
ubgroups. Tables 6 and 7 detail three-year risk-adjusted
ates of cardiac death as derived from the final multivariable
odel in patients with known CAD and suspected CAD by
eight and MPS groups and other patient subsets. The
redicted rates of cardiac death shown represent the average
alue for individuals in each group. In each BMI category,
nd in patients with suspected as well as known CAD,
ardiac death rate increased as scan abnormality increased
Tables 6 and 7). In patients with known CAD (Table 6),
here was a trend toward decreasing event rates as weight
ncreased, particularly in patients with moderately to se-
erely abnormal MPS, adenosine stress, lower LVEF, and
lderly women. Cox proportional hazard analyses performed
n these subgroups revealed the following: after adjusting for
ther significant predictors, lower BMI remained significant
or predicting cardiac death in patients with abnormal MPS,
able 4. Multivariable Model for Prediction of Cardiac Death
n Patients With Known CAD
HR (95% CI)
Wald
Chi-Square p Value
denosine stress 2.94 (2.24–3.86) 59.9 0.000
myo stress 1.02 (1.02–1.03) 28.2 0.000
nlarged LV 2.05 (1.55–2.71) 25.8 0.000
ge by groups* 1.37 (1.21–1.56) 23.6 0.000
est heart rate 1.02 (1.01–1.03) 19.8 0.000
ypercholesterolemia 0.67 (0.53–0.85) 10.4 0.001
bnormal rest ECG 3.83 (1.69–8.70) 10.3 0.001
MI 0.95 (0.92–0.98) 10.3 0.001
hortness of breath 1.56 (1.16–2.10) 8.6 0.003
igoxin use 1.52 (1.15–2.02) 8.6 0.003
iabetes 1.45 (1.12–1.88) 8.1 0.004
ale gender 0.18 (0.04–0.87) 4.5 0.033
MI  gender 1.07 (1.01–1.14) 4.9 0.026
Age is categorized as 40, 40–49, 50–59, 60–69, 70–79, and 80 years old.
BMI  body mass index; CI  confidence interval; HR  hazard ratio; other
bbreviations as in Tables 2 and 3.
able 5. Multivariable Model for Prediction of Cardiac Death
n Patients With Suspected CAD
HR (95% CI)
Wald
Chi-Square p Value
myo stress 1.05 (1.04–1.06) 65.0 0.000
ge by groups* 1.64 (1.39–1.93) 34.4 0.000
denosine stress 2.65 (1.87–3.77) 29.6 0.000
bnormal rest ECG 2.39 (1.48–3.88) 12.5 0.000
nlarged LV 1.98 (1.33–2.96) 11.2 0.001
hortness of breath 1.90 (1.29–2.79) 10.6 0.001
iabetes 1.67 (1.19–2.34) 8.8 0.003
igoxin use 1.69 (1.14–2.52) 6.7 0.010
est heart rate 1.01 (1.001–1.021) 4.5 0.034
MI 0.98 (0.95–1.01) 1.3 NSAge is categorized as 40, 40–49, 50–59, 60–69, 70–79, and 80 years old.
Abbreviations as in Tables 2, 3, and 4. Adenosine stress, lower EF, women in both age groups (p 
.05) but not in patients with normal MPS, exercise stress,
F 45%, or male gender (p  0.20). Risk-adjusted
robabilities of cardiac death were similar among weight
ategories in patients with suspected CAD (Table 7). Cox
roportional hazard analysis confirmed that there were no
ignificant differences between weight groups after risk
djustment (p  0.20). Patients with lower EF and normal
eight appeared to have a higher death probability than the
eavier patients, but this difference was not significant,
robably because of small number in this subgroup.
utcomes in women. Risk-adjusted survival curves by
ategories of weight in women with known CAD and
uspected CAD undergoing adenosine MPS are illustrated
n Figures 4 and 5. Survival analysis was not performed in
omen undergoing exercise MPS due to a small number of
ardiac deaths (n  12). In women with known CAD, a
ignificant decrease in survival was noted with decreasing
eight after adjustment for other significant predictors
able 6. Three-Year Risk-Adjusted Rates of Cardiac Death
n Patients With Known CAD by MPS Results, Gender, Age,
tress Type, and LVEF
Normal Weight
% (n)
Overweight
% (n)
Obese
% (n)
ormal 3.3 (605) 2.3 (642) 1.8 (272)
ildly abnormal 5.3 (378) 4.5 (405) 3.3 (180)
od-Sev abnormal 12.0 (882) 8.5 (982) 6.3 (374)
en 7.4 (1,309) 6.0 (1,566) 5.1 (529)
70 yrs 4.2 (586) 3.8 (878) 4.2 (384)
70 yrs 10.0 (723) 8.8 (688) 7.4 (145)
omen 8.8 (556) 4.7 (463) 2.6 (297)
70 yrs 3.6 (164) 2.7 (190) 2.2 (169)
70 yrs 10.9 (392) 6.1 (273) 3.2 (128)
xercise 3.4 (1,100) 2.6 (1,208) 2.2 (465)
denosine stress 14.2 (765) 10.4 (821) 6.7 (361)
VEF 45% 5.0 (397) 3.4 (444) 2.4 (198)
VEF 45% 15.2 (195) 12.3 (196) 8.3 (100)
AD  coronary artery disease; LVEF  left ventricular ejection fraction; Mod-Sev 
oderately to severely; MPS  myocardial perfusion single-photon emission com-
uted tomography.
able 7. Three-Year Risk-Adjusted Rates of Cardiac Death
n Patients With Suspected CAD by MPS Results, Gender,
ge, Stress Type, and LVEF
Normal Weight
% (n)
Overweight
% (n)
Obese
% (n)
ormal 1.1 (3,137) 1.0 (3,211) 1.0 (1,671)
ildly abnormal 3.0 (367) 2.2 (469) 2.4 (252)
od-Sev abnormal 7.5 (346) 7.8 (393) 6.1 (173)
en 2.0 (1,828) 1.7 (2,538) 1.5 (1,006)
70 yrs 0.7 (1,134) 0.8 (1,817) 0.9 (786)
70 yrs 4.1 (694) 4.1 (721) 3.8 (220)
omen 1.7 (2,022) 1.8 (1,535) 1.6 (1,090)
70 yrs 0.6 (1,047) 0.8 (823) 0.9 (754)
70 yrs 2.9 (975) 3.0 (712) 3.2 (336)
xercise 0.8 (2,691) 0.8 (2,890) 0.6 (1,308)
denosine stress 4.4 (1,159) 4.1 (1,183) 3.2 (788)
VEF 45% 1.5 (1,290) 1.3 (1,366) 1.2 (803)
VEF 45% 14.0 (76) 9.1 (96) 7.0 (72)bbreviations as in Table 6.
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nd stress defect percent, with the highest survival in obese
omen, the worst survival in normal weight women (p 
.001 across groups) (Fig. 4). In women with suspected
AD, there were no significant differences in survival between
bese and non-obese patients after adjusting for age, diabetes,
esting ECG, and stress defect percent (Fig. 5).
ISCUSSION
o our knowledge, this is the first study that investigated
he impact of weight as presented by BMI on cardiac death
n patients undergoing rest and stress MPS. In this study of
4,739 patients, the findings indicate that obese or over-
eight patients with or without known CAD who had
ormal MPS were at low risk of cardiac death (1% per
ear), similar to normal weight patients. The percent myo-
igure 4. Risk-adjusted survival curves for cardiac death by categories of
yocardial perfusion single-photon emission computed tomography. Mar
owest survival in normal weight women. p  0.001 across groups.
igure 5. Risk-adjusted survival curves for cardiac death by categories of w
yocardial perfusion single-photon emission computed tomography. There were
or all comparisons.ardium with stress defect was a strong predictor of cardiac
eath in all weight groups. Cardiac death rates rose uni-
ormly as the percent myocardium with stress perfusion
efects increased. Thus, our data demonstrate that MPS has
significant prognostic value for overweight and obese
atients as well as for those of normal weight.
Of interest, in patients with known CAD, BMI was
nversely related to cardiac death (i.e., an increased BMI is
ssociated with a decreased risk of cardiac death); this was
articularly notable for patients with abnormal MPS, low
F, undergoing adenosine stress, and women. Patients with
AD and lower BMI had significant higher risk of cardiac
eath than the other subsets. This significantly higher death
ate was still observed when the first-year cardiac deaths
ere excluded, and was present when the first-year cardiac
eaths were analyzed separately. Although normal weight
hts in women with known coronary artery disease undergoing adenosine
ifferences were noted, with the highest survival in obese women, and the
s in women with suspected coronary artery disease undergoing adenosineweigeight
no significant differences between obese and non-obese patients. p  NS
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April 4, 2006:1418–26 Prognostic Impact of BMI on SPECTatients were older than heavier patients, following risk-
djustment by age and other significant covariates, lower BMI
emained independently predictive of cardiac death. However,
MI did not affect the risk of cardiac death in patients with
uspected CAD.
omparison to previous studies. Because this is the first
eport of the influence of obesity on the prognostic impli-
ations of MPS, there is no literature to directly compare
he observations. While it is well known that obesity
ncreases the risk of cardiovascular disease and mortality in
he general population (2,3,26,27), this relationship is mul-
ifactorial and complex.
Our finding that BMI was inversely related to the rate of
ardiac death in some subgroups is consistent with several
ther published observations (6–10,28,29). Obesity appears
o be a “risk factor” for the development of CAD but
ossibly not a “risk marker” (29). Obesity has been reported
o be less of a prognostic factor in patients with known
AD (8–10). In some prior observations, obesity has also
een shown to be protective, and termed an “obesity
aradox” (30) or “reverse epidemiology” (7). In a study of
orwich et al. (6), commented on by others (7,30), obesity
as found to confer a favorable prognosis in patients with
HF. Lopez-Jimenez et al. (8) studied outcomes after MI
nd found that overweight and obese patients had a lower
ortality compared to patients with normal weight. Recent
ata also have shown a possible protective effect of obesity
n outcomes after PCI (9) or CABG (10). Minutello et al.
9) analyzed 95,435 patients undergoing PCI who with
MI 30 to 40 kg/m2 had lower in-hospital mortality and
ajor adverse cardiac events than lower weight patients.
ruberg et al. (10) reported overweight or obese patients
ad significantly better outcomes than those with normal
MI who underwent CABG.
ossible explanations for obesity being a reverse predic-
or of cardiac death in patients with known CAD. In the
.S., despite the growing prevalence of overweight and
bese people (31), there has been a marked decline in
ardiovascular mortality over the past 30 years (32,33). It is
ossible that an increase in CAD related to the increase in
ody weight has had little effect on recent mortality data as
result of more aggressive medical management and much
ower levels of other coronary risk factors than in previous
ecades (34).
Several possible explanations for increased risk in patients
ith lower weight have been described. For example, in
HF, a malnutrition/inflammation complex syndrome has
een postulated as conferring increased risk in patients with
ower weights (6). These same investigators have suggested
hat a greater tolerance in obese and overweight patients of
ngiotensin-converting enzyme inhibitor therapy may be
laying a protective role. A more likely explanation of the
obesity paradox” in our study is the difference between
ong-term and short-term risk. We evaluated relatively
hort-term mortality—mean follow-up time in the known
AD group was only 2.7 years. Obesity may confer a ahort-term survival benefit previously observed in post-MI,
ost-revascularization, and CHF cohorts, but at the same
ime might result in worsened long-term outcome; over a
rolonged time, acceleration of the underlying cardiovascu-
ar disease process by obesity would be expected to become
vident.
tudy limitations. Current SPECT cameras have a maxi-
al allowable weight of approximately 400 lbs. Accordingly,
here were only 1% to 2% of patients with BMI 40 kg/m2
n this study, and some severely obese who might have been
t very high risk of mortality would not be included in this
tudy. Our findings could have been related to a “survival
ias.” As a group, the normal weight patients were older and
ore often women than the heavier patients, especially in
hose with known CAD. The obese patients who live longer
ay represent the subset of the healthy obese. While the
isk-adjusted analysis attempts to take these differences into
ccount, they may still affect the results. Additionally, the
xistence of comorbidities and other prognostically impor-
ant factors (i.e., physical activity, abdominal obesity, details
f medical therapy) not recorded in our database, might
ave influenced the findings. Furthermore, a referral bias
ay be active such that obese patients with lower risk may
e more likely to be referred for testing than normal weight
atients of similar risk. Also, our results are based on a
opulation referred for nuclear testing in a single center in
outhern California and therefore may not be applicable to
broader population.
Gated MPS was performed only in the subset studied
fter 1994, because this approach was not available before
hat year. While it might be possible that increased artifacts
ue to soft tissue attenuation in the obese patients could
ave confounded the prognostic analysis of MPS, we have
ecently demonstrated that the size of perfusion defects and
he diagnostic accuracy of MPS in our laboratory is not
ifferent between normal weight, overweight, and obese
atients (35).
onclusions. Stress defect by MPS is a strong predictor of
ardiac death and valuable for risk stratification for those
ith a normal weight to obese patients. Patients who are
verweight or obese and have normal MPS are at low risk
or cardiac death. The rate of cardiac death rises as a
unction of MPS abnormality in all weight groups with and
ithout known CAD. Body mass index does not affect the
isk of cardiac death in patients with suspected CAD. Body
ass index is an independent inverse predictor of cardiac
eath in patients with known CAD, with this effect being
ost marked in patients undergoing adenosine stress, hav-
ng abnormal perfusion, or lower LVEF by MPS, and in
omen.
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